Analysts at Deutsche Bank upgraded Check Point Software Technologies Ltd. CHKP 0.05% from Hold to Buy and raised their price target from $70.00 to $90.00. Check Point develops, markets and supports software for information technology security.
Bill Ackman, activist investor and CEO of Pershing Square Capital Management, spoke on Bloomberg TV this morning about one of his fund’s most controversial positions: a $1 billion short sale of Herbalife Ltd HLF 0.16%. So far, 2014 has been a good year for Ackman and other Herbalife shorts, as the stock has fallen nearly 54 percent year to date.
According to a recent report by Morgan Stanley, U.S. investors shouldn’t be fearful that economic weakness elsewhere in the world will drag the U.S. economy back into another recession. Decoupling From Europe Over the past three quarters, U.S. industrial production (IP) has risen year-over-year by 3.5 percent, 4.7 percent, and 4.9 percent respectively. With IP growth…
“Crash” is not a word that gets taken lightly in the financial world. When markets crash, people lose jobs, personal savings are wiped out, companies and economies fail, and fear (both rational and irrational) reigns supreme. Oil Spooks Investors Over the past few months, oil has experienced a crash in price.
Analysts at Wedbush on Tuesday initiated coverage of Infinera Corp. INFN 1.57% by issuing a Neutral rating and setting a $13 price target. Infinera provides optical networking equipment and services to communications providers, iInternet providers, cable operators and other network operators worldwide. The Numbers Infinera’s previous quarterly earnings numbers in October were quite good. The company announced earnings per share of…
Wunderlich Securities recently released a report detailing their 2015 outlook for the onshore oilfield services industry. It might come as little surprise that analysts’ projections for the sector are grim. Massive Spending Cuts Analysts expect a huge reduction in CapEx by many oil companies in 2015, and some of the cuts have already been revealed. ConocoPhillips COP 1.76% is…
Wunderlich Securities recently released a report in which analysts drastically cut their outlook for crude oil prices. In the report, analysts explain how they see the oilfield services sector adapting to the new low-price environment. The report also includes several names on which Wunderlich remains bullish. How Will Companies Adapt? It is widely expected that many…
Analysts at MLV & Co on Tuesday initiated coverage of Tenax Therapeutics Inc TENX 2.32% with a Buy rating and $7 price target. Tenax is a biotechnology company that focuses on localized oxygen delivery. Levosimendan Tenax is currently undergoing Phase III trials of its drug levosimendan, which is a calcium sensitizer. Levosimendan is currently being tested for its…
In a recent report, Morgan Stanley analysts laid out their case for why Nike Inc NKE 2.31% will continue to outperform in the next three years. Analysts cite Nike’s superior innovation and marketing execution, its increasing presence in growing worldwide markets, and the overall worldwide trend toward healthy living as three major drivers of a 9 percent compound annual growth…
A new Morgan Stanley report looks at the potential for an acceleration of merger and acquisition (M&A) activity among mid-cap banks in 2015. Analysts give several reasons why they believe a recent modest increase in M&A activity in the financial sector could pick up next year. Many banks have benefited from cost-cutting measures and reserve releases over…